• Artelo Biosciences, Inc. Announces Closing of $7.6 Million Underwritten Public Offering and Full Exercise of Underwriters' Option

    13 days ago - By San Diego Biotechnology

    LA JOLLA, Calif., Oct. 14, 2020 - Artelo Biosciences, Inc. , a clinical stage biopharmaceutical company focused on developing and commercializing treatments intended to modulate endogenous signaling pathways, including......
    Read more ...